Prenatal screening continues to advance rapidly, yet detecting rare musculoskeletal disorders in utero remains clinically challenging. Arthrogryposis multiplex congenita represents a heterogeneous group of conditions defined by congenital contractures in at least two separate body regions. Historically, prenatal ultrasound identifies fewer than half of affected fetuses before birth, which limits crucial delivery planning and parental counseling. Fortunately, modern kinematic evaluations and advanced genetics now significantly improve timely prenatal detection.

Understanding Arthrogryposis Multiplex Congenita and Diagnostic Hurdles

The term arthrogryposis multiplex congenita does not specify a single disease entity, but rather describes a physical symptom resulting from reduced fetal movement. Multiple etiologies impair fetal mobility in utero, including motor neuropathies, primary muscle disorders, maternal connective tissue diseases, metabolic conditions, and restrictive intrauterine crowding. Consequently, prolonged fetal akinesia causes periarticular connective tissue to proliferate, freezing developing joints in fixed positions. Despite widespread second-trimester anomaly scans across maternal health systems, clinicians frequently overlook early markers of contractures. For instance, operators often attribute subtle limb flexion to normal resting postures or transient uterine positioning. Furthermore, routine obstetrical screening protocols traditionally prioritize standard biometric planes and major organ anatomy rather than dynamic limb movements. As a result, many families receive an unexpected diagnosis only in the delivery room, completely missing opportunities for early intervention. Therefore, maternal-fetal medicine teams require heightened vigilance whenever sonography demonstrates persistent limb posturing, unusual clubfoot, or reduced fetal activity.

Systematic Evaluation of Dynamic Fetal Motor Assessment

To overcome diagnostic oversights, maternal-fetal specialists now integrate systematic fetal motor assessment into standard prenatal imaging workflows. Instead of capturing static two-dimensional biometric snapshots, sonographers actively observe dynamic motor patterns across several minutes. A healthy fetus typically displays diverse, fluid kinematics, including spontaneous limb flexion, extension, startling, breathing movements, and frequent finger adjustments. In contrast, fetuses developing joint contractures demonstrate rigid posturing and marked reductions in both the frequency and quality of movements. Sonographers should therefore observe whether hands open spontaneously or remain tightly clenched. Furthermore, examiners must verify whether the fetal elbows, knees, and ankles actively flex and extend over a fifteen-minute scanning period. If initial movements appear absent or severely restricted, clinicians should schedule follow-up ultrasound scans two weeks later. This longitudinal surveillance differentiates transient fetal sleep cycles from genuine neurogenic or myogenic akinesia. Ultimately, evaluating dynamic fetal motor behavior transforms prenatal scanning from passive observation into a reliable functional diagnostic tool.

Sonographic Markers and Structural Anomaly Protocols

Comprehensive ultrasound imaging remains the cornerstone of prenatal evaluation when clinicians suspect fetal akinesia or contractures. Clinicians must actively search for characteristic structural anomalies that frequently accompany restricted fetal mobility. Bilateral clubfoot represents the most common initial clue, occurring in more than half of affected fetuses. However, clinicians must recognize that clubfoot rarely occurs in isolation in syndromic cases; rather, it often coexists with fixed wrists, hyperextended knees, or camptodactyly. In addition, chronic lack of fetal movement frequently produces secondary facial anomalies, such as micrognathia and retrognathia. Impaired fetal swallowing also frequently induces progressive polyhydramnios, serving as an important indirect clue of neuromuscular dysfunction. When acoustic windows prove challenging, ultrafast fetal magnetic resonance imaging offers valuable supplemental anatomy. Specifically, magnetic resonance imaging provides exceptional visualization of cerebral development, spinal cord integrity, and fetal muscle mass. Consequently, combining targeted neurosonography with magnetic resonance imaging enables accurate identification of underlying central nervous system anomalies and thoracic hypoplasia.

Phenotypic Classification: AMC Groups 1 Through 3

Establishing an accurate prognosis requires maternal-fetal medicine teams to categorize affected fetuses into established phenotypic groups. Group 1 comprises conditions with isolated limb involvement, where amyoplasia and distal arthrogryposis represent the predominant diagnoses. In classic amyoplasia, symmetric limb contractures occur with muscle hypoplasia, yet affected children usually retain normal intelligence and achieve favorable functional outcomes through orthopedic rehabilitation. Group 2 encompasses joint contractures associated with major congenital anomalies in other organ systems. These presentations frequently involve congenital heart defects, abdominal wall defects, or craniofacial clefts, indicating complex syndromic or chromosomal disorders with variable long-term prognoses. Finally, Group 3 consists of severe contractures accompanied by fatal central nervous system impairment or lethal fetal akinesia deformation sequence. Fetuses in Group 3 typically exhibit severe pulmonary hypoplasia, micrognathia, polyhydramnios, and profound intrauterine growth restriction. Because Group 3 conditions carry extremely high perinatal mortality, distinguishing these groups during pregnancy proves critical. Thus, precise phenotypic grouping directly informs parental discussions regarding delivery room resuscitation or compassionate palliative pathways.

Diagnostic Yield of Next-Generation Genomic Sequencing

Genetic testing has emerged as a transformative diagnostic modality for investigating congenital contractures identified during pregnancy. Traditional chromosomal microarray analysis identifies copy number variations in approximately ten percent of cases. In contrast, rapid prenatal exome sequencing and whole genome sequencing dramatically increase diagnostic yield by an additional thirty to forty percent. These high-throughput genomic technologies systematically analyze hundreds of candidate genes encoding neuromuscular junction proteins, sarcomeric components, and motor neuron pathways. For example, sequencing frequently detects pathogenic variants in acetylcholine receptor genes, which carry specific autosomal recessive recurrence risks for future pregnancies. Furthermore, establishing a molecular diagnosis during pregnancy refines clinical prognostication and prevents unnecessary invasive postnatal diagnostic testing. In addition, identifying specific maternal antibodies targeting fetal acetylcholine receptors can identify asymptomatic mothers with transient fetal myasthenia gravis, opening opportunities for maternal immunomodulatory therapies in future pregnancies. Therefore, prenatal genetics services should routinely integrate rapid exome sequencing into multidisciplinary diagnostic algorithms for all fetuses with multiple contractures.

Multidisciplinary Pathways and Future Global Collaborations

Optimal clinical management of contractures requires a structured multidisciplinary care pathway established before delivery. Once prenatal imaging confirms multiple joint contractures, maternal-fetal medicine specialists must coordinate with pediatric orthopedists, neonatologists, medical geneticists, and pediatric neurologists. Together, this specialized team develops an individualized birth plan that addresses potential airway difficulties secondary to micrognathia and prepares for prompt orthopedic splinting after birth. Additionally, clinicians must actively incorporate patient-reported experiences and collaborate with patient support organizations to address parental psychosocial needs. Looking forward, international clinical registries are establishing standardized data collection protocols that track affected individuals from fetal life through adulthood. Such collaborative global repositories will clarify natural disease history, validate novel predictive biomarkers, and refine personalized prenatal counseling frameworks. Moreover, international consensus will drive future research into targeted fetal and neonatal interventions for neuromuscular disorders. Ultimately, structured clinical care pathways and cross-border research collaborations empower healthcare teams to deliver evidence-based, compassionate care for families confronting this challenging condition.

Frequently Asked Questions

At what gestational age is arthrogryposis multiplex congenita typically detected?

Clinicians most frequently detect contractures between 18 and 22 weeks of gestation during routine mid-trimester structural anomaly scans. However, severe akinesia and increased nuchal translucency can appear as early as 12 weeks. Conversely, mild distal contractures may only become apparent in the third trimester as intrauterine space diminishes. Therefore, serial ultrasound scans throughout pregnancy remain essential whenever clinicians suspect diminished fetal movement.

How does systematic motor assessment differentiate arthrogryposis from isolated clubfoot?

Systematic motor assessment evaluates kinematic patterns across the entire fetus over extended observation times. Isolated clubfoot displays active knee motion, spontaneous hand opening, normal breathing movements, and typical swallowing dynamics. In contrast, arthrogryposis presents with generalized hypokinesia, fixed limb posturing, and absence of spontaneous finger extension across multiple anatomical joints. Thus, observing real-time movements prevents clinicians from misdiagnosing a systemic neuromuscular disorder as isolated talipes.

What is the diagnostic yield of genomic sequencing for prenatally detected contractures?

Chromosomal microarray analysis identifies pathogenic variants in approximately 10 percent of fetuses with multiple contractures. However, adding rapid prenatal exome sequencing or whole genome sequencing provides a molecular diagnosis in an additional 30 to 40 percent of cases. Monogenic variants affecting neuromuscular junctions, sarcomeres, and motor neurons cause most cases. Consequently, international guidelines strongly advocate exome sequencing for comprehensive prenatal genetic workups.

Disclaimer: This content is for informational and educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis, or treatment. Refer to the latest local and national guidelines for clinical practice.

References

1. Arduç A et al. Prenatal Detection of Arthrogryposis Multiplex Congenita, Present State and Future Perspectives. Am J Med Genet C Semin Med Genet. 2026 Nov 05. doi: 10.1002/ajmg.c.70028. PMID: 42988753.


2. Ruano R, et al. Prenatal diagnosis and prognostic factors in fetuses with Arthrogryposis Multiplex Congenita - a systematic review. Am J Obstet Gynecol MFM. 2025;7(2):101340.


3. Hall JG. Arthrogryposis (multiple congenital contractures): diagnostic approach to etiology, classification, genetics, and general principles. Eur J Med Genet. 2014;57(8):464-472.